- Alnylam to pay $30M upfront to AI startup Inceptive in RNA R&D dealAlnylam Pharmaceuticals announced its first discovery-focused AI deal Wednesday, tapping a Silicon Valley biotech startup to see if AI can boost its R&D efforts. Alnylam and Inceptive signed…Endpoints · 1mo ago↗ source
- Bristol Myers turns focus to AI costs after broad rollout to workersPALO ALTO, CA — After giving artificial intelligence tools to thousands of employees, Bristol Myers Squibb is now working to get a handle on the costs of the technology and where it’s actually crea…Endpoints · 1mo ago↗ source
- Axsome pushes back generic entry for narcolepsy drug until 2040Axsome Therapeutics has successfully delayed generic competition for its narcolepsy drug Sunosi until 2040. The company announced on Wednesday that it has reached a settlement with the last appli…